Tech Company Financing Transactions

Eikon Therapeutics Funding Round

Abu Dhabi Investment Authority, AME Cloud Ventures and Canada Pension Plan Investment Board joined a $517.8 million Series B funding round for Eikon Therapeutics. This venture round was announced on 1/7/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3929 Point Eden Way
Hayward, CA 94545
USA

Phone

Undisclosed

Website

www.eikontx.com

Email Address

Not Recorded

Overview

Eikon Therapeutics is a drug discovery and development company. Our proprietary platform leverages super-resolution microscopy, a Nobel Prize-winning technology, as well as the latest advances in biology, chemistry, engineering, and automation toward the goal of developing and bringing to market novel therapies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Roger Perlmutter

        

Chief Scientific Officer

Daniel Anderson

        

Browse more venture capital transactions:

Prev: 1/7/2022: Amberstone Biosciences venture capital transaction
Next: 1/7/2022: CellPoint Digital venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary